3320
COM:CRPHARM
华润医药集团有限公司
- Stock
Last Close
5.33
22/11 08:08
Market Cap
34.24B
Beta: -
Volume Today
12.67M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 6.91B - | 6.92B 0.14% | 2.85B 58.83% | 2.82B 1.01% | 3.48B 23.45% | 3.98B 14.20% | 3.29B 17.38% | 3.30B 0.33% | 3.77B 14.31% | 4.15B 10.04% | 4.26B 2.69% | |
depreciation and amortization | 1.20B - | 1.35B 13.14% | 1.27B 6.31% | 1.18B 6.67% | 1.45B 22.72% | 1.52B 4.52% | 2.36B 55.85% | 2.44B 3.35% | 2.82B 15.46% | 3.15B 11.70% | 3.50B 10.93% | |
deferred income tax | -6.72B - | -7.72B 14.87% | ||||||||||
stock based compensation | 1.43M - | 116.20M 8,003.35% | ||||||||||
change in working capital | -3.70B - | -3.64B 1.62% | -6.38B 75.23% | -13.24B 107.69% | -5.26B 60.28% | -3.34B 36.49% | -2.01B 39.79% | -3.76B 87.02% | 300.32M 107.98% | -934.80M 411.27% | 1.77B 289.30% | |
accounts receivables | -7.85B - | -7.43B 5.35% | -6.22B 16.32% | -8.74B 40.49% | -4.51B 48.33% | -3.37B 25.33% | -7.59B 125.09% | -5.12B 32.51% | -5.20B 1.50% | -8.02B 54.35% | -7.00B 12.76% | |
inventory | -1.10B - | -3.78B 245.53% | -157.60M 95.83% | -4.51B 2,759.47% | -746.25M 83.44% | 29.48M 103.95% | -537.47M 1,922.93% | -805.55M 49.88% | -3.41B 323.40% | -2.64B 22.72% | -2.95B 11.86% | |
accounts payables | 7.85B - | 7.43B 5.35% | 4.14B 44.28% | 9.19B 121.97% | 106.79M 98.84% | 223.66M 109.44% | 6.19B 2,667.41% | 1.54B 75.10% | 7.54B 389.06% | 9.36B 24.24% | 12.06B 28.76% | |
other working capital | 5.25B - | 7.58B 44.37% | -4.14B 154.65% | -9.19B 121.97% | -106.79M 98.84% | -223.66M 109.44% | -77.02M 65.57% | 622.72M 908.56% | 1.37B 120.34% | 360.28M 73.74% | -338.95M 194.08% | |
other non cash items | -307.48M - | -449.96M 46.34% | 8.25B 1,932.95% | 13.36B 61.97% | 5.18B 61.20% | 6.09B 17.55% | 1.61B 73.50% | 4.30B 166.22% | 11.04B 156.95% | 12.13B 9.85% | 10.37B 14.56% | |
net cash provided by operating activities | 4.10B - | 4.19B 2.06% | 5.99B 43.04% | 4.12B 31.21% | 4.86B 17.91% | 8.25B 69.78% | 5.25B 36.29% | 6.28B 19.47% | 11.22B 78.75% | 10.90B 2.87% | 15.01B 37.70% | |
investments in property plant and equipment | -3.00B - | -3.19B 6.45% | -1.82B 42.82% | -1.72B 5.75% | -1.57B 8.83% | -1.52B 3.20% | -2.04B 34.54% | -2.22B 8.72% | -2.90B 30.85% | -3.36B 15.62% | -3.46B 3.14% | |
acquisitions net | -3.58B - | -1.02B 71.55% | -398.88M 60.83% | -2.83B 609.37% | -2.03B 28.40% | -4.05B 99.84% | 1.03B 125.56% | -82.95M 108.02% | -1.01B 1,118.84% | -572.16M 43.41% | 4.96B 967.70% | |
purchases of investments | -4.32B - | -15.06B 248.46% | -17.42B 15.70% | -15.92B 8.63% | -8.57B 46.14% | -3.52B 58.89% | -1.60B 54.52% | -371.45M 76.83% | -1.09B 194.46% | -3.05B 178.63% | -26.69B 775.71% | |
sales maturities of investments | 2.93B - | 10.95B 274.32% | 15.58B 42.25% | 18.34B 17.77% | 3.26B 82.25% | 16.99B 421.64% | 130.23M 99.23% | 536.44M 311.93% | 337K 99.94% | 16.33M 4,746.88% | 25.76B 157,636.18% | |
other investing activites | 2.18B - | 336.54M 84.58% | 149.69M 55.52% | 170.87M 14.15% | 398.04M 132.95% | -17.70B 4,546.48% | 3.52B 119.89% | 114.78M 96.74% | -3.83B 3,432.77% | 3.66B 195.71% | 60.86M 98.34% | |
net cash used for investing activites | -5.79B - | -7.98B 37.84% | -3.92B 50.88% | -1.95B 50.17% | -8.51B 335.81% | -9.80B 15.15% | 1.04B 110.63% | -2.02B 294.05% | -8.83B 336.90% | -3.30B 62.66% | 640.59M 119.42% | |
debt repayment | -27.75B - | -38.25B 37.85% | -44.21B 15.58% | -45.21B 2.25% | -52.09B 15.22% | -70.28B 34.93% | -19.59B 72.12% | -207.27M 98.94% | -7.66B 3,593.65% | -5.06B 33.96% | -219.90M 95.65% | |
common stock issued | 5.28B - | 15.06B - | -684.78M - | -691.06M 0.92% | 3.36B 585.98% | |||||||
common stock repurchased | -145.44M - | -86.76M 40.34% | -483.44M 457.21% | -571.10M 18.13% | ||||||||
dividends paid | -565.61M - | -691.30M 22.22% | -816.99M 18.18% | -691.08M 15.41% | -753.90M 9.09% | -942.38M 25.00% | -972.36M 3.18% | |||||
other financing activites | 26.48B - | 41.34B 56.15% | 42.66B 3.19% | 29.52B 30.80% | 55.78B 88.96% | 75.64B 35.60% | 11.31B 85.05% | -1.87B 116.56% | 14.50B 874.34% | -5.88B 140.54% | -3.12B 46.86% | |
net cash used provided by financing activities | 4.01B - | 3.09B 22.91% | -1.55B 150.30% | -625.46M 59.76% | 3.13B 599.93% | 4.67B 49.27% | -9.10B 295.04% | -3.60B 60.44% | 5.31B 247.54% | -9.00B 269.42% | -5.58B 38.00% | |
effect of forex changes on cash | 159.66M - | -737.39M 561.86% | -1.04B 40.53% | -783.82M 24.36% | 729.64M 193.09% | -651.80M 189.33% | -228.07M 65.01% | -853.81M 274.36% | -362.69M 57.52% | -429.26M 18.35% | ||
net change in cash | 2.48B - | -1.44B 158.00% | -521.00M 63.81% | 757.31M 245.36% | 202.48M 73.26% | 2.46B 1,115.71% | -2.92B 218.76% | 584.80M 120.00% | 7.60B 1,200.33% | -1.21B 115.91% | 10.75B 988.65% | |
cash at beginning of period | 12.69B - | 15.18B 19.55% | 13.74B 9.49% | 13.21B 3.79% | 13.97B 5.73% | 14.17B 1.45% | 20.06B 41.53% | 17.14B 14.57% | 17.72B 3.41% | 25.33B 42.91% | 24.12B 4.78% | |
cash at end of period | 15.18B - | 13.74B 9.49% | 13.21B 3.79% | 13.97B 5.73% | 14.17B 1.45% | 16.64B 17.37% | 17.14B 3.02% | 17.72B 3.41% | 25.33B 42.91% | 24.12B 4.78% | 34.87B 44.57% | |
operating cash flow | 4.10B - | 4.19B 2.06% | 5.99B 43.04% | 4.12B 31.21% | 4.86B 17.91% | 8.25B 69.78% | 5.25B 36.29% | 6.28B 19.47% | 11.22B 78.75% | 10.90B 2.87% | 15.01B 37.70% | |
capital expenditure | -3.00B - | -3.19B 6.45% | -1.82B 42.82% | -1.72B 5.75% | -1.57B 8.83% | -1.52B 3.20% | -2.04B 34.54% | -2.22B 8.72% | -2.90B 30.85% | -3.36B 15.62% | -3.46B 3.14% | |
free cash flow | 1.11B - | 998.15M 9.81% | 4.17B 317.33% | 2.40B 42.36% | 3.29B 37.05% | 6.73B 104.52% | 3.21B 52.25% | 4.06B 26.30% | 8.32B 104.93% | 7.54B 9.32% | 11.55B 53.08% |
All numbers in (except ratios and percentages)